Myeloma Clinical Trials
The following is a listing of myeloma clinical trials associated with this tag.
All Clinical Trials
View all active clinical trials around the US.
Verified
Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)
IBERDOMIDE AS MAINTENANCE THERAPYSparkCures Verified Accurate, up-to-date information. Learn more
A Phase 1 Study of Adding Venetoclax to a Reduced Intensity Conditioning Regimen and to Maintenance in Comb...
VENETOCLAX IN PRE- AND POST-TRANSPLANT THERAPYA Phase Ib Study of Oral Decitabine/Cedazuridine as Maintenance Therapy Following Allogeneic Hematopoietic ...
DECITABINE/CEDAZURIDINE AS MAINTENANCE THERAPYA Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a ...
TRIPLET INDUCTION + 1 OR 2-DRUG MAINTENANCEBelantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
BELANTAMAB MAFODOTIN COMBINATION THERAPYMeasurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
MRD-GUIDED ELRANATAMAB MAINTENANCE THERAPYMinimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autolo...
BELANTAMAB MAFODOTIN OR LENALIDOMIDE MAINTENANCEPost-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
POST-TRANSPLANT MAINTENANCE THERAPYPre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With...
PRE AND POST TRANSPLANT ELRANATAMABRandomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multip...
IBERDOMIDE VS. OBSERVATION POST IDE-CEL CAR-T
Untreated / Newly Diagnosed Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
SparkCures Verified Accurate, up-to-date information. Learn more
A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a ...
TRIPLET INDUCTION + 1 OR 2-DRUG MAINTENANCEMeasurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
MRD-GUIDED ELRANATAMAB MAINTENANCE THERAPYMinimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autolo...
BELANTAMAB MAFODOTIN OR LENALIDOMIDE MAINTENANCEPre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With...
PRE AND POST TRANSPLANT ELRANATAMAB
Early Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
Late Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multip...
IBERDOMIDE VS. OBSERVATION POST IDE-CEL CAR-T
Smoldering Myeloma
No active clinical trials
Monoclonal Gammopathy of Undetermined Significance (MGUS)
No active clinical trials